WUXI BIO (02269) announced on September 19 that it will spend 17.5452 million Hong Kong dollars to repurchase 146.8 million shares.
WuXi Biologics (02269) announced that the company spent HK$175.452 million on September 19, 2024...
WUXI BIO (02269) announced that on September 19, 2024, the company repurchased 1.468 million shares at a price of 11.72-12.06 Hong Kong dollars per share, with a total expenditure of 17.5452 million Hong Kong dollars.
On the same day, in accordance with the Company's Pre-IPO Stock Option Plan adopted on January 5, 2016 (revised on August 10, 2016), 373,800 ordinary shares were issued for the exercise of options.
Related Articles
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Hims & Hers Health (HIMS.US) launches cheap weight loss pills, FDA stops sales the next day, stock price plummets after hours.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Hims & Hers Health (HIMS.US) launches cheap weight loss pills, FDA stops sales the next day, stock price plummets after hours.
